Syndax Pharmaceuticals (SNDX) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions of board members, executive team, and auditors, and outlined the agenda including a Q&A session after formal business.

• Formal business to follow the notice and proxy statement, with five proposals to be considered.

Board and executive committee updates

• Board members and executive officers were introduced, including CEO, CFO, general counsel, and external auditors.

Shareholder proposals

• Five proposals presented: election of two class 1 directors, advisory approval of executive compensation, ratification of auditors, approval of 2026 Equity Incentive Plan, and approval of 2026 Employee Stock Purchase Plan.